title: Purinergic receptors in embryonic and adult neurogenesis.
abstract: ATP (adenosine 5'-triphosphate), one of the most ancient neurotransmitters, exerts essential functions in the brain, including neurotransmission and modulation of synaptic activity. Moreover, this nucleotide has been attributed with trophic properties and experimental evidence points to the participation of ATP-activated P2X and P2Y purinergic receptors in embryonic brain development as well as in adult neurogenesis for maintenance of normal brain functions and neuroregeneration upon brain injury. We discuss here the available data on purinergic P2 receptor expression and function during brain development and in the neurogenic zones of the adult brain, as well as the insights based on the use of in vitro stem cell cultures. While several P2 receptor subtypes were shown to be expressed during in vitro and in vivo neurogenesis, specific functions have been proposed for P2Y1, P2Y2 metabotropic as well as P2X2 ionotropic receptors to promote neurogenesis. Further, the P2X7 receptor is suggested to function in the maintenance of pools of neural stem and progenitor cells through induction of proliferation or cell death, depending on the microenvironment. Pathophysiological actions have been proposed for this receptor in worsening damage in brain disease. The P2X7 receptor and possibly additional P2 receptor subtypes have been implicated in pathophysiology of neurological diseases including Parkinson's disease, Alzheimer's disease and epilepsy. New strategies in cell therapy could involve modulation of purinergic signaling, either in the achievement of more effective protocols to obtain viable and homogeneous cell populations or in the process of functional engraftment of transplanted cells into the damaged brain. This article is part of the Special Issue entitled 'Purines in Neurodegeneration and Neuroregeneration'.
authors.affiliation: Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP 05508-900, Av. Prof. Lineu Prestes, 748, Brazil.
authors.forename: Ágatha
authors.initials: Á
authors.lastname: Oliveira
authors.affiliation: Rudolf-Boehm-Institut für Pharmakologie und Toxikologie der Universität Leipzig, Haertelstrasse 16-18, 04107 Leipzig, Germany. Electronic address: peter.illes@medizin.uni-leipzig.de.
authors.forename: Peter
authors.initials: P
authors.lastname: Illes
authors.affiliation: Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP 05508-900, Av. Prof. Lineu Prestes, 748, Brazil. Electronic address: henning@iq.usp.br.
authors.forename: Henning
authors.initials: H
authors.lastname: Ulrich
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000196:embryology / Q000378:metabolism*; D002454:Cell Differentiation; D004827:Epilepsy / Q000378:metabolism / Q000628:therapy; D006801:Humans; D058953:Neural Stem Cells / Q000378:metabolism; D055495:Neurogenesis; D010300:Parkinson Disease / Q000378:metabolism / Q000628:therapy; D058469:Receptors, Purinergic P2X / Q000378:metabolism*; D058486:Receptors, Purinergic P2X7 / Q000378:metabolism; D058470:Receptors, Purinergic P2Y / Q000378:metabolism*; D058472:Receptors, Purinergic P2Y1 / Q000378:metabolism; D015398:Signal Transduction; D033581:Stem Cell Transplantation
chemical_list: D058469:Receptors, Purinergic P2X; D058486:Receptors, Purinergic P2X7; D058470:Receptors, Purinergic P2Y; D058472:Receptors, Purinergic P2Y1; D000255:Adenosine Triphosphate
keywords: Cell therapy; Neural embryonic development; Neural stem cells; Neurodegenerative disorders; Purinergic receptors